GBT 440-007 A Phase 2a, Open-label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Exploratory Treatment Effect of GBT440 in Adolescents with Sickle Cell Disease

Project: Research project

Project Details

StatusActive
Effective start/end date7/1/166/30/21

Funding

  • Global Blood Therapeutics, Inc.
  • Global Blood Therapeutics, Inc.